WSHA has been in contact with Health Care Authority (HCA) staff regarding the status of payments following the audit of Medicaid electronic health record (EHR) incentive payments. ... Read More >>
While revenue collections in the state continue to be strong, it appears that policy decisions made to fund future costs in the McCleary bill in the 2017-2019 biennium may limit the legislature’s ability to spend money on any additional policy items without new revenue or cuts in other programs. ... Read More >>
WSHA testified Monday at the Senate Committee on Health & Long Term Care regarding SB 5031 and SB 5699, which prohibits providers from balance billing patient for out-of-network services in certain circumstances.... Read More >>
WSHA opposes HB 1531, which places restrictions on interest for medical debt. ... Read More >>
The American Hospital Association (AHA) and a group of hospitals filed a brief to US District Court specifying relief for 340B program hospitals that received a thirty percent cut to Medicare payment for drugs provided under the 340B program. ... Read More >>
WSHA contacted and received confirmation from Noridian Healthcare Solutions that the partial federal shutdown should cause no disruptions to Medicare payments. ... Read More >>
WSHA recently commented with concerns about the second pre-draft rules by the state Department of Labor & Industries (L&I) that would expand the class of workers who qualify for overtime pay. ... Read More >>
WSHA’s Government Affairs team has published its January 2019 state regulatory update to its State Regulatory Issues webpage.... Read More >>
On Dec. 27, a federal judge ruled that the Department of Health and Human Services’ (HHS’s) nearly 30-percent cut to Medicare payment rates for many hospitals participating in the 340B drug discount program was unlawful.... Read More >>
Section 216 of the Protecting Access to Medicare Act of 2014 (PAMA), requires certain clinical laboratories to collect and provide the Centers for Medicare and Medicaid Services (CMS) information regarding commercial payor rates for purposes of calculating the Medicare Clinical Lab Fee Schedule.... Read More >>
